The global gap in treatment coverage for major depressive disorder in 84 countries from 2000–2019: A systematic review and Bayesian meta-regression analysis
University of Washington · Institute for Health Metrics and Evaluation · +3 more institutions
Abstract
BACKGROUND: The treatment coverage for major depressive disorder (MDD) is low in many parts of the world despite MDD being a major contributor to disability globally. Most existing reviews of MDD treatment coverage do not account for potential sources of study-level heterogeneity that contribute to variation in reported treatment rates. This study aims to provide a comprehensive review of the evidence and analytically quantify sources of heterogeneity to report updated estimates of MDD treatment coverage and gaps by location and treatment type between 2000 and 2019. METHODS AND FINDINGS: A systematic review of the literature was conducted to identify relevant studies that provided data on treatment rates for…
Citation impact
- FWCI
- 60.33
- Percentile
- 100%
- References
- 36
Authors
7- MMModhurima Moitra
University of Washington, Institute for Health Metrics and Evaluation
- DSDamian Santomauro
The University of Queensland, University of Washington, Institute for Health Metrics and Evaluation, Queensland Centre for Mental Health Research
- PYPamela Y. Collins
University of Washington
- TVTheo Vos
University of Washington, Institute for Health Metrics and Evaluation
- HWHarvey Whiteford
The University of Queensland, University of Washington, Institute for Health Metrics and Evaluation, Queensland Centre for Mental Health Research
Topics & keywords
- Major depressive disorder
- Meta-analysis
- Meta-regression
- Covariate
- Medicine
- Study heterogeneity
- Population
- Sample size determination
- No poverty